Recently, Irani and colleagues proposed a C-terminal cleaved isoform cystatin C (12.5kDa) in cerebrospinal fluid as a marker of multiple sclerosis. In this study, we demonstrate that the 12.5kDa product of cystatin C is formed by degradation of the first eight N-terminal residues. Moreover, such a degradation is not specific in the cerebrospinal fluid of multiple sclerosis, but rather is given by an inappropriate sample storage at -20 degrees C. We conclude that the use of the 12.5kDa product of cystatin C in cerebrospinal fluid might lead to a fallacious diagnosis of multiple sclerosis. Preanalytical validation procedure is mandatory for proteomics investigations.
Cleavage of cystatin C is not associated with multiple sclerosis
DEL BOCCIO, PIERO;PIERAGOSTINO, DAMIANA;LUGARESI, Alessandra;DI IOIA, MARIA;PAVONE, Barbara;TRAVAGLINI, DANIELA;SACCHETTA, Paolo;DI ILIO, Carmine;GAMBI, Domenico;URBANI, ANDREA
2007-01-01
Abstract
Recently, Irani and colleagues proposed a C-terminal cleaved isoform cystatin C (12.5kDa) in cerebrospinal fluid as a marker of multiple sclerosis. In this study, we demonstrate that the 12.5kDa product of cystatin C is formed by degradation of the first eight N-terminal residues. Moreover, such a degradation is not specific in the cerebrospinal fluid of multiple sclerosis, but rather is given by an inappropriate sample storage at -20 degrees C. We conclude that the use of the 12.5kDa product of cystatin C in cerebrospinal fluid might lead to a fallacious diagnosis of multiple sclerosis. Preanalytical validation procedure is mandatory for proteomics investigations.File | Dimensione | Formato | |
---|---|---|---|
AnnNeu_CysC_20968.pdf
Solo gestori archivio
Tipologia:
Documento in Post-print
Dimensione
151.44 kB
Formato
Adobe PDF
|
151.44 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.